- Home
- OP vs AIMD Comparison
OP vs AIMD Comparison
Compare OP & AIMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OP
- AIMD
- Stock Information
- Founded
- OP 2021
- AIMD 1984
- Country
- OP Greece
- AIMD United States
- Employees
- OP 106
- AIMD N/A
- Industry
- OP
- AIMD Biotechnology: Pharmaceutical Preparations
- Sector
- OP
- AIMD Health Care
- Exchange
- OP Nasdaq
- AIMD Nasdaq
- Market Cap
- OP 8.5M
- AIMD 8.5M
- IPO Year
- OP N/A
- AIMD N/A
- Fundamental
- Price
- OP $1.13
- AIMD $0.59
- Analyst Decision
- OP
- AIMD
- Analyst Count
- OP 0
- AIMD 0
- Target Price
- OP N/A
- AIMD N/A
- AVG Volume (30 Days)
- OP 10.9K
- AIMD 1.3M
- Earning Date
- OP 12-20-2024
- AIMD 03-07-2025
- Dividend Yield
- OP N/A
- AIMD N/A
- EPS Growth
- OP N/A
- AIMD N/A
- EPS
- OP N/A
- AIMD N/A
- Revenue
- OP $25,729,000.00
- AIMD $40,633.00
- Revenue This Year
- OP N/A
- AIMD N/A
- Revenue Next Year
- OP N/A
- AIMD N/A
- P/E Ratio
- OP N/A
- AIMD N/A
- Revenue Growth
- OP 36.33
- AIMD N/A
- 52 Week Low
- OP $1.02
- AIMD $0.40
- 52 Week High
- OP $3.15
- AIMD $3.10
- Technical
- Relative Strength Index (RSI)
- OP 40.22
- AIMD 46.09
- Support Level
- OP $1.11
- AIMD $0.57
- Resistance Level
- OP $1.24
- AIMD $0.64
- Average True Range (ATR)
- OP 0.05
- AIMD 0.09
- MACD
- OP -0.00
- AIMD -0.02
- Stochastic Oscillator
- OP 7.17
- AIMD 10.62
About OP OceanPal Inc.
OceanPal Inc is a provider of shipping transportation services. It specializes in the ownership of vessels. Each of its vessels is owned through a separate wholly-owned subsidiary.
About AIMD Ainos Inc.
Ainos Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low-dose oral form. Its product pipeline includes VELDONA Pet cytoprotein supplements for pets, VELDONA human therapeutics for clinical use, and telehealth-friendly POCTs powered by the AI Nose technology platform.